Medical Device Solutions

Surface Finish & Biocompatibility

A laser-cut edge is never directly implantable. The recast layer (re-solidified metal), HAZ, and oxidation products from cutting must be removed through post-processing to achieve a biocompatible surface that won't trigger adverse tissue reactions or accelerate corrosion in the body.

Quick Answer

The standard post-laser finishing sequence for implants: 1) Acid pickling (remove recast/slag), 2) Electropolishing (smooth surface to Ra < 0.4μm), 3) Passivation(rebuild protective oxide layer), 4) Final cleaning (ultrasonic + DI water rinse). The finished surface must pass ISO 10993 biocompatibility testing (2025 revision enhances risk-based approach) for the intended contact duration and type.

Post-Laser Finishing Sequence

StepProcessPurposeTypical Ra After
0. As-cutBaseline (recast + HAZ present)1–5μm Ra
1. Acid picklingHF/HNO₃ immersionRemove recast, oxides, slag0.5–2μm Ra
2. ElectropolishingAnodic dissolution in electrolyteSmooth surface, remove micro-burrs0.1–0.4μm Ra
3. PassivationCitric/nitric acid treatmentForm protective Cr₂O₃ or TiO₂ layerUnchanged
4. Final cleaningUltrasonic + DI water + dryRemove all chemical residuesUnchanged

Material-Specific Finishing

Stainless Steel (316LVM)

  • • Electropolish: H₃PO₄/H₂SO₄ electrolyte, 40–60°C
  • • Passivation: citric acid per ASTM A967
  • • Target Ra: < 0.25μm for implant contact
  • • Cr/Fe ratio > 1.5 verified by XPS
  • • Blue passivation test per ASTM F1089

Nitinol

  • • Critical: minimize Ni surface concentration
  • • Shape-set before electropolish (preserve geometry)
  • • Electropolish: methanol/HClO₄, −30°C to −40°C
  • • Target: TiO₂-rich surface layer with Ni < 2 at%
  • • Corrosion testing per ASTM F2129

Titanium (Ti-6Al-4V ELI)

  • • Acid etch: HF/HNO₃ to remove alpha-case
  • • No standard electropolishing (anodizing optional)
  • • Micro-blasting for textured osseointegration surfaces
  • • Target Ra depends on application (smooth vs textured)
  • • Passivation per ASTM F86

CoCr Alloys (L-605)

  • • Electropolish: H₃PO₄-based at 50–70°C
  • • Very hard material — longer electropolish cycle
  • • Target Ra: < 0.2μm for stent applications
  • • Co ion release testing per ISO 10993-12
  • • High corrosion resistance in body fluids

Related Topics

Disclaimer: Surface finishing for medical devices must be validated per FDA QMSR (incorporating ISO 13485:2016) requirements. Chemical formulations and parameters are reference starting points. Consult with your finishing supplier and regulatory team for device-specific protocols.